Topical Corticosteroids Market Report 2026

Topical Corticosteroids Market Overview

• Topical Corticosteroids market size has reached to $9.17 billion in 2025 • Expected to grow to $13.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Incidence Of Skin Disorders Fueling Market Growth Due To Stressful Lifestyles And Poor Skin Health • Market Trend: Adoption Of Nanoparticle-Based Ophthalmic Corticosteroids Driving Innovation In The Topical Corticosteroids Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Topical Corticosteroids Market?

Topical corticosteroids refers to medications that are applied directly to the skin to reduce inflammation, redness, and itching by mimicking the effects of hormones produced by the adrenal glands. They work by suppressing the immune response in the affected area, helping to treat various skin conditions such as eczema, psoriasis, and dermatitis. The main types of topical corticosteroids are prescription and over-the-counter (OTC). A prescription is an order from a doctor or other licensed healthcare provider that lets a patient get and use certain medicines that cannot be bought without a doctor’s approval. The multiple medications involved are ointments, creams, liquids and solutions, lotions, gels, oils, pastes, sprays, and others that are distributed through various distribution channels such as hospital pharmacies, pharmacy stores, online pharmacies, and others and are used for various applications such as acne, dermatitis, psoriasis, skin infections, hyperpigmentation, melasma, and others and cater to several end users such as hospitals, dermatology clinics, home care, and others.

What Is The Topical Corticosteroids Market Growth Forecast?

The topical corticosteroids market size is expected to see strong growth in the next few years. It will grow to $13.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to development of novel low-side-effect formulations, growth of otc hydrocortisone products, increasing adoption of online pharmacies, rising demand for personalized dermatology treatments, expansion of homecare-based skin treatment solutions. Major trends in the forecast period include rising prevalence of chronic skin disorders, growing demand for over-the-counter corticosteroid products, increased use of combination topical therapies, expansion of online and retail pharmacy distribution, rising focus on safer low-potency and long-term use formulations.

What Is The Driver Of The Topical Corticosteroids Market?

The rising incidence of skin disorders is expected to propel the growth of the topical corticosteroids market going forward. Skin disorders refer to a wide range of conditions that affect the skin’s appearance, structure, or function, potentially impacting overall health, comfort, and quality of life. The rising incidence of skin disorders is due to increasing stress in modern lifestyles characterized by long working hours, poor diets, and prolonged screen exposure, which negatively affect skin health and drive individuals to seek effective skincare and dermatological solutions. Topical corticosteroids help manage skin disorders by reducing inflammation, itching, and redness by suppressing overactive immune responses, making them essential for treating conditions such as eczema, psoriasis, and dermatitis For instance, in September 2024, according to Cancer Australia, an Australia-based government agency, it was estimated that there were 18,257 new melanoma cases diagnosed in 2023 and 1,314 deaths in the same year. Therefore, the rising incidence of skin disorders is driving the growth of the topical corticosteroids industry.

Key Players In The Global Topical Corticosteroids Market

Major companies operating in the topical corticosteroids market are Merck & Co. Inc., GSK plc , Teva Pharmaceutical Industries Ltd., Sandoz International GmbH , Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Menarini Group, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited , LEO Pharma A/S, Taro Pharmaceutical Industries Ltd., Ajanta Pharma Ltd., Micro Labs Ltd., FDC Limited, Harrow Inc., Salve Pharmaceuticals Pvt. Ltd., Lincoln Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd.

Global Topical Corticosteroids Market Trends and Insights

Major companies operating in the topical corticosteroids market are increasingly focusing on nanoparticle-based corticosteroid formulations to meet the rising demand for safer, more consistent, and more effective post-surgical anti-inflammatory therapies. A nanoparticle-based corticosteroid formulation is a drug delivery system where corticosteroids are loaded into tiny nanoparticles to improve skin penetration, provide controlled drug release, and reduce systemic side effects. For instance, in September 2024, Eyenovia, a US-based ophthalmic pharmaceutical company, launched clobetasol propionate ophthalmic suspension 0.05%, a next-generation corticosteroid formulated with Formosa Pharmaceuticals’ APNT nanoparticle technology. The product delivers a stable nanosuspension that maintains uniformity throughout the bottle, supports twice-daily dosing, and provides rapid pain and inflammation relief following ocular surgery, with clinical data showing complete pain resolution in approximately 80% of patients by day 4. Its formulation minimizes adverse events and represents the first new ophthalmic steroid to reach the US market in more than 15 years, improving both patient experience and clinical outcomes

What Are Latest Mergers And Acquisitions In The Topical Corticosteroids Market?

In June 2025, Harrow, a US-based ophthalmic pharmaceutical company, acquired the exclusive U.S. commercial rights to BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05% from Formosa Pharmaceuticals for an undisclosed amount. With this acquisition, Formosa will continue to operate independently, while Harrow will commercialize BYQLOVI, a topical corticosteroid, in the U.S. market, ensuring continuity in product delivery and brand presence. Formosa Pharmaceuticals is a Taiwan-based biopharmaceutical company specializing in the development of innovative ophthalmic topical corticosteroids and oncology drug formulations.

What Defines the Topical Corticosteroids Market?

The topical corticosteroids market consists of sales of creams, ointments, lotions, gels, and foams. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Topical Corticosteroids Market Report 2026?

The topical corticosteroids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the topical corticosteroids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.